First Command Advisory Services’s GSK GSK Stock Holding History

First Command Advisory Services’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$22.5K	Sell	428 -871	-67%	-$46.1K	﹤0.01%	631
2026 Q1	$71.8K	Buy	1,299 +744	+134%	+$40.3K	﹤0.01%	299
2025 Q4	$27.2K	Hold	555	–	–	﹤0.01%	380
2025 Q3	$24K	Hold	555	–	–	﹤0.01%	375
2025 Q2	$21.3K	Sell	555 -59	-10%	-$2.25K	﹤0.01%	361
2025 Q1	$23.8K	Buy	614 +156	+34%	+$5.71K	﹤0.01%	335
2024 Q4	$15.5K	Hold	458	–	–	﹤0.01%	364
2024 Q3	$18.7K	Hold	458	–	–	﹤0.01%	346
2024 Q2	$17.6K	Sell	458 -105	-19%	-$4.42K	﹤0.01%	325
2024 Q1	$24.1K	Buy	563 +105	+23%	+$4.33K	﹤0.01%	309
2023 Q4	$17K	Hold	458	–	–	﹤0.01%	319
2023 Q3	$16.6K	Buy	+458	New	+$16.3K	﹤0.01%	314
2023 Q1	–	Sell	-1,380	Closed	–	–	152
2022 Q4	$0	Buy	+1,380	New	+$46K	﹤0.01%	109

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

First Command Advisory Services's GSK Position: Q2 2026 in Review

First Command Advisory Services reduced its GSK (GSK) stake by 67% in Q2 2026, selling an estimated $46.1K and leaving 428 shares worth $22.5K. The position accounts for ﹤0.01% of the portfolio, ranked #631.

First Command Advisory Services first reported a position in GSK in Q4 2022 and has held it in 13 quarters since. The position peaked at $71.8K in Q1 2026. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

First Command Advisory Services held 428 shares of GSK worth $22.5K as of Q2 2026.
First Command Advisory Services sold 871 GSK shares in Q2 2026, an estimated $46.1K.
GSK made up ﹤0.01% of First Command Advisory Services's portfolio in Q2 2026, its #631 holding.
First Command Advisory Services first reported a position in GSK in Q4 2022 and has held it in 13 quarters since.
First Command Advisory Services's GSK position peaked at $71.8K in Q1 2026.
1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on First Command Advisory Services's 13F filing for Q2 2026, filed 10 Aug 2026.